Oncorus Performance
| ONCRDelisted Stock | USD 0.04 0.01 14.71% |
The company holds a Beta of 0.58, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Oncorus' returns are expected to increase less than the market. However, during the bear market, the loss of holding Oncorus is expected to be smaller as well. Oncorus right now holds a risk of 0.0%. Please check Oncorus treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Oncorus will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Oncorus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Oncorus is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 104.2 M |
Oncorus |
Oncorus Relative Risk vs. Return Landscape
If you would invest 4.35 in Oncorus on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Oncorus or generate 0.0% return on investment over 90 days. Oncorus is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Oncorus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Oncorus Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncorus' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Oncorus, and traders can use it to determine the average amount a Oncorus' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ONCR |
Based on monthly moving average Oncorus is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncorus by adding Oncorus to a well-diversified portfolio.
Oncorus Fundamentals Growth
Oncorus Stock prices reflect investors' perceptions of the future prospects and financial health of Oncorus, and Oncorus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Oncorus Stock performance.
| Return On Equity | -1.25 | |||
| Return On Asset | -0.32 | |||
| Current Valuation | 25.71 M | |||
| Shares Outstanding | 26.09 M | |||
| Price To Book | 0.13 X | |||
| EBITDA | (75.42 M) | |||
| Cash And Equivalents | 100.24 M | |||
| Cash Per Share | 3.86 X | |||
| Total Debt | 70.65 M | |||
| Debt To Equity | 0.72 % | |||
| Book Value Per Share | 1.19 X | |||
| Cash Flow From Operations | (61.69 M) | |||
| Earnings Per Share | (5.49) X | |||
| Total Asset | 145.59 M | |||
| Retained Earnings | (272.01 M) | |||
About Oncorus Performance
Assessing Oncorus' fundamental ratios provides investors with valuable insights into Oncorus' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Oncorus is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Oncorus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.Things to note about Oncorus performance evaluation
Checking the ongoing alerts about Oncorus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Oncorus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Oncorus is not yet fully synchronised with the market data | |
| Oncorus has some characteristics of a very speculative penny stock | |
| Oncorus has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (77.42 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Oncorus currently holds about 100.24 M in cash with (61.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 55.0% of the company shares are owned by institutional investors |
- Analyzing Oncorus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Oncorus' stock is overvalued or undervalued compared to its peers.
- Examining Oncorus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Oncorus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Oncorus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Oncorus' stock. These opinions can provide insight into Oncorus' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Oncorus Stock
If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |